Aitechpark12 Jul, 2021Technology
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (?PureTech? or the ?Company?), a clinical-stage biotherapeutics company, is pleased to note that its Founded Entity, Sonde Health (?Sonde?), today announced that it will collaborate with leading chipmaker Qualcomm Technologies, Inc. (?Qualcomm?) to optimize use of Sonde?s vocal biomarker technology on the flagship and high-tier Qualcomm? Snapdragon? 888 and 778G 5G Mobile Platforms to help bring native, machine learning-driven vocal biomarker capabilities to mobile and IoT devices globally. The optimization has the potential to unlock several native health screening and monitoring applications on up to the hundreds of millions of mobile devices that use these Snapdragon mobile platforms.
Dr. Aneel Kumar
School Ml — Introducing Machine Learning In The
Ashley Emerson
Erungasliva Reddy
Yo88
Mnm3d
Baji Bd
Nhà Cái Kuwin
Abigail Adeline
Bücher Slots